Since neuroinflammatory, amyloid and vascular burdens can be evaluated in vivo by specific neuroimaging approaches (e.g., TSPO-specific PET tracer for neuroinflammation [101], amyloid PET and specific MRI sequences for amyloid and vascular alterations, respectively), LC-MRI represents a very interesting opportunity to assess the abovementioned correlations in vivo also in AD patients. This evidence concerns the gene TSPO and Alzheimer disease.